Error: Could not add to watchlist. X

Summit Therapeutics PLC

+ Watchlist
UVF:GR
Ticker Change
UVF:GR has changed to a new ticker symbol
EUR
Volume
0
Previous Close
0.08
Volume
0
Previous Close
0.08
Current P/E Ratio (TTM)
-
Earnings per Share (GBP) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Summit Therapeutics PLC is a drug discovery and development Company targeting areas of high unmet medical need. The Company is advancing two clinical-stage programmes: Utrophin modulators for the treatment of all genetic forms of the fatal disease, Duchenne Muscular Dystrophy, and a novel antibiotic for the selective treatment of infections caused by C. difficile bacteria.
ADDRESS
85b Park Drive Milton Park
Abingdon, Oxfordshire
Oxfordshire
United Kingdom
PHONE
44-123-544-3939
  • Glyn O Edwards
    Chief Executive Officer
  • Erik Ostrowski
    Chief Financial Officer
  • Jonathon Tinsley
    Chief Scientific Officer
  • Richard Vickers
    Chief Scientific Officer
  • Bina Tejura
    VP:Clinical Development
Show More